share_log

Schnieders Capital Management LLC Trims Stock Position in Medical Properties Trust, Inc. (NYSE:MPW)

Schnieders Capital Management LLC Trims Stock Position in Medical Properties Trust, Inc. (NYSE:MPW)

施尼德資本管理有限責任公司修剪醫療財產信託公司(紐約證券交易所代碼:MPW)的股票頭寸
Financial News Live ·  2023/02/07 12:33

Schnieders Capital Management LLC cut its position in shares of Medical Properties Trust, Inc. (NYSE:MPW – Get Rating) by 2.2% during the third quarter, Holdings Channel.com reports. The firm owned 292,193 shares of the real estate investment trust's stock after selling 6,500 shares during the quarter. Schnieders Capital Management LLC's holdings in Medical Properties Trust were worth $3,465,000 at the end of the most recent quarter.

據Holdings Channel.com報道,Schnieders Capital Management LLC在第三季度將其在醫療地產信託公司(NYSE:MPW-GET Rating)的股票頭寸削減了2.2%。該公司在本季度出售了6,500股後,持有292,193股這家房地產投資信託基金的股票。截至最近一個季度末,Schnieders Capital Management LLC持有的醫療地產信託價值346.5萬美元。

A number of other institutional investors also recently bought and sold shares of the company. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Medical Properties Trust by 14.4% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 273,002 shares of the real estate investment trust's stock worth $3,238,000 after purchasing an additional 34,281 shares during the period. California Public Employees Retirement System raised its stake in Medical Properties Trust by 17.1% during the third quarter. California Public Employees Retirement System now owns 1,369,436 shares of the real estate investment trust's stock worth $16,242,000 after purchasing an additional 199,619 shares during the period. Vicus Capital purchased a new position in Medical Properties Trust during the third quarter worth about $272,000. Metis Global Partners LLC raised its stake in Medical Properties Trust by 56.3% during the third quarter. Metis Global Partners LLC now owns 16,411 shares of the real estate investment trust's stock worth $195,000 after purchasing an additional 5,914 shares during the period. Finally, IFP Advisors Inc raised its stake in shares of Medical Properties Trust by 13.8% in the 3rd quarter. IFP Advisors Inc now owns 10,084 shares of the real estate investment trust's stock valued at $118,000 after acquiring an additional 1,223 shares during the period. 80.31% of the stock is owned by hedge funds and other institutional investors.

其他一些機構投資者最近也買賣了該公司的股票。Zurcher Kantonalbank蘇黎世廣東銀行在第三季度增持了14.4%的醫療財產信託股份。Zurcher Kantonalbank蘇黎世廣東銀行在此期間又購買了34,281股,現在擁有273,002股這家房地產投資信託基金的股票,價值3,238,000美元。加州公共僱員退休系統在第三季度將其在醫療財產信託公司的持股增加了17.1%。加州公共僱員退休系統現在擁有1,369,436股房地產投資信託基金的股票,價值16,242,000美元,在此期間又購買了199,619股。Vicus Capital在第三季度購買了一個新的醫療財產信託頭寸,價值約27.2萬美元。Metis Global Partners LLC在第三季度將其在Medical Properties Trust的持股增加了56.3%。Metis Global Partners LLC在此期間又購買了5,914股,現在擁有這家房地產投資信託基金16,411股股票,價值19.5萬美元。最後,IFP Advisors Inc.在第三季度將其在Medical Properties Trust的股份增加了13.8%。IFP Advisors Inc目前持有這家房地產投資信託基金10,084股股票,價值11.8萬美元,在此期間又收購了1,223股。80.31%的股票由對衝基金和其他機構投資者持有。

Get
到達
Medical Properties Trust
醫療財產信託基金
alerts:
警報:

Medical Properties Trust Stock Down 0.4 %

醫療地產信託股價下跌0.4%

NYSE MPW traded down $0.05 on Tuesday, hitting $12.44. 4,208,935 shares of the stock were exchanged, compared to its average volume of 12,485,226. The company has a quick ratio of 1.98, a current ratio of 1.98 and a debt-to-equity ratio of 1.07. Medical Properties Trust, Inc. has a fifty-two week low of $9.90 and a fifty-two week high of $22.11. The company has a market cap of $7.44 billion, a PE ratio of 6.00, a PEG ratio of 0.72 and a beta of 0.93. The company has a 50-day moving average price of $12.29 and a 200-day moving average price of $13.03.

週二,紐約證交所MPW股價下跌0.05美元,至12.44美元。該股共成交4,208,935股,而其平均成交量為12,485,226股。該公司的速動比率為1.98,流動比率為1.98,債務權益比率為1.07。醫療地產信託公司的股價為52周低點9.90美元和52周高點22.11美元。該公司市值為74.4億美元,市盈率為6.00倍,聚乙二醇率為0.72倍,貝塔係數為0.93。該公司的50日移動均線價格為12.29美元,200日移動均線價格為13.03美元。

Medical Properties Trust Dividend Announcement

醫療財產信託分紅公告

The company also recently declared a quarterly dividend, which was paid on Thursday, January 12th. Shareholders of record on Thursday, December 8th were issued a dividend of $0.29 per share. This represents a $1.16 annualized dividend and a yield of 9.32%. The ex-dividend date was Wednesday, December 7th. Medical Properties Trust's dividend payout ratio (DPR) is presently 55.77%.
該公司最近還宣佈了季度股息,股息於1月12日星期四支付。12月8日(星期四)登記在冊的股東獲得了每股0.29美元的股息。這意味着年化股息為1.16美元,收益率為9.32%。除息日期是12月7日星期三。醫療財產信託的股息支付率(DPR)目前為55.77%。

Analysts Set New Price Targets

分析師設定新的價格目標

A number of equities research analysts have recently issued reports on MPW shares. Barclays reduced their price target on shares of Medical Properties Trust from $19.00 to $17.00 and set an "overweight" rating on the stock in a research note on Friday, January 27th. Mizuho reduced their price target on shares of Medical Properties Trust from $20.00 to $18.00 in a research note on Friday, December 2nd. Bank of America raised shares of Medical Properties Trust from a "neutral" rating to a "buy" rating and boosted their price target for the company from $13.00 to $16.00 in a research note on Monday, November 14th. They noted that the move was a valuation call. StockNews.com started coverage on shares of Medical Properties Trust in a research note on Wednesday, October 12th. They issued a "hold" rating on the stock. Finally, KeyCorp reduced their price target on shares of Medical Properties Trust from $18.00 to $16.00 and set an "overweight" rating on the stock in a research note on Thursday, January 19th. Six research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $16.55.

許多股票研究分析師最近發佈了關於MPW股票的報告。巴克萊銀行在1月27日星期五的一份研究報告中將醫療地產信託公司的股票目標價從19.00美元下調至17.00美元,並對該股設定了“增持”評級。瑞穗在12月2日星期五的一份研究報告中將醫療地產信託的目標價從20.00美元下調至18.00美元。11月14日,美國銀行在一份研究報告中將醫療地產信託公司的股票評級從中性上調至買入,並將該公司的目標價從13.00美元上調至16.00美元。他們指出,此舉是一次估值預測。StockNews.com在10月12日星期三的一份研究報告中開始報道醫療財產信託公司的股票。他們對該股的評級為“持有”。最後,KeyCorp在1月19日(星期四)的一份研究報告中將醫療財產信託公司的股票目標價從18.00美元下調至16.00美元,並對該股設定了“增持”評級。6名研究分析師對該股的評級為持有,4名分析師給出了買入評級,一名分析師對該股發出了強烈的買入評級。根據MarketBeat的數據,該股目前的平均評級為“適度買入”,共識目標價為16.55美元。

Medical Properties Trust Company Profile

醫療財產信託公司簡介

(Get Rating)

(獲取評級)

Medical Properties Trust, Inc is a self-advised real estate investment trust, engages in the investment, acquisition, and development of net-leased healthcare facilities. Its property portfolio includes rehabilitation hospitals, long-term acute care hospitals, ambulatory surgery centers, hospitals for women and children, regional and community hospitals, medical office buildings, and other single-discipline facilities.

醫療財產信託公司是一家自營的房地產投資信託公司,從事投資、收購和開發淨租賃醫療設施。其資產組合包括康復醫院、長期急性護理醫院、門診手術中心、婦女和兒童醫院、地區和社區醫院、醫療辦公樓和其他單一學科設施。

Featured Stories

專題報道

  • Get a free copy of the StockNews.com research report on Medical Properties Trust (MPW)
  • Hertz Global Holding Could Be A Comfortable Ride In 2023
  • Should Investors Buy or Sell the Vaccinex Patent News?
  • Take-Two Interactive Or Activision Blizzard: An Obvious Choice?
  • What is a Penny Stock? What You Need to Know About Penny Stocks
  • ServiceNow CEO Sells Shares, Is It Time To Worry?
  • 免費獲取StockNews.com關於醫療財產信託(MPW)的研究報告
  • 赫茲全球控股可能成為2023年的舒適之旅
  • 投資者應該買入還是賣出Vaccinex專利新聞?
  • Take-Two互動版還是動視暴雪:顯而易見的選擇?
  • 什麼是便士股票?你需要知道的關於細價股的事情
  • ServiceNow CEO拋售股票,是時候擔心了嗎?

Want to see what other hedge funds are holding MPW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medical Properties Trust, Inc. (NYSE:MPW – Get Rating).

想看看還有哪些對衝基金持有MPW嗎?訪問HoldingsChannel.com,獲取醫療地產信託公司(NYSE:MPW-GET Rating)的最新13F文件和內幕交易。

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.

每天收到醫療財產信託的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對醫療物業信託和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論